Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Freedman

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|December 10, 2013
Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterationsHongmei Nan, Teppei Morikawa, Miia Suuriniemi, et al.
Elife|September 12, 2017
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancerNeel Shah, Ping Wang, John Wongvipat, et al.
Cancer Research|October 26, 2017
Cross-Cancer Analysis Reveals Novel Pleiotropic Associations-ResponseRayjean J Hung, Gordon Fehringer, Graham Casey, et al.
European Urology|June 4, 2023
Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven ProgramsSimon Linder, Tesa M Severson, Koen J C van der Mijn, et al.
Cancer Research Communications|August 8, 2024
MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate CancerBeatriz German, Sarah A Alaiwi, Kun-Lin Ho, et al.
Cancer Cell|December 4, 2018
Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic LeukemiaChristopher J Ott, Alexander J Federation, Logan S Schwartz, et al.
Nature Communications|December 16, 2021
Androgen receptor and MYC equilibration centralizes on developmental super-enhancerHaiyang Guo, Yiming Wu, Mannan Nouri, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Genome-wide association study of prostate cancer mortalityKathryn L Penney, Saumyadipta Pyne, Fredrick R Schumacher, et al.
The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.
Nature Genetics|May 27, 2011
Principles for the post-GWAS functional characterization of cancer risk lociMatthew L Freedman, Alvaro N A Monteiro, Simon A Gayther, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|December 10, 2013
Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterationsHongmei Nan, Teppei Morikawa, Miia Suuriniemi, et al.
Elife|September 12, 2017
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancerNeel Shah, Ping Wang, John Wongvipat, et al.
Cancer Research|October 26, 2017
Cross-Cancer Analysis Reveals Novel Pleiotropic Associations-ResponseRayjean J Hung, Gordon Fehringer, Graham Casey, et al.
European Urology|June 4, 2023
Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven ProgramsSimon Linder, Tesa M Severson, Koen J C van der Mijn, et al.
Cancer Research Communications|August 8, 2024
MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate CancerBeatriz German, Sarah A Alaiwi, Kun-Lin Ho, et al.
Cancer Cell|December 4, 2018
Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic LeukemiaChristopher J Ott, Alexander J Federation, Logan S Schwartz, et al.
Nature Communications|December 16, 2021
Androgen receptor and MYC equilibration centralizes on developmental super-enhancerHaiyang Guo, Yiming Wu, Mannan Nouri, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Genome-wide association study of prostate cancer mortalityKathryn L Penney, Saumyadipta Pyne, Fredrick R Schumacher, et al.
The Lancet. Oncology|December 11, 2012
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort studyFabio A B Schutz, Mark M Pomerantz, Kathryn P Gray, et al.
Nature Genetics|May 27, 2011
Principles for the post-GWAS functional characterization of cancer risk lociMatthew L Freedman, Alvaro N A Monteiro, Simon A Gayther, et al.
Pageof 18